Oric Pharmaceuticals Inc (ORIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -73,703 | -26,883 | -21,363 | N/A | N/A |
| Depreciation Amortization | 1,269 | 1,028 | 903 | N/A | N/A |
| Other Working Capital | 2,045 | 1,220 | -707 | N/A | N/A |
| Other Operating Activity | 25,121 | 1,102 | 484 | 0 | 0 |
| Operating Cash Flow | $-45,268 | $-23,533 | $-20,683 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -215,485 | N/A | N/A | N/A | N/A |
| PPE Investments | -667 | -768 | -525 | N/A | N/A |
| Other Investing Activity | 193 | 0 | 17 | 0 | 0 |
| Investing Cash Flow | $-215,959 | $-768 | $-508 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 271,751 | 131 | 79 | N/A | N/A |
| Other Financing Activity | -21,237 | 70,693 | 37,929 | 0 | 0 |
| Financing Cash Flow | $250,514 | $70,824 | $38,008 | $N/A | $N/A |
| Beginning Cash Position | 89,159 | 42,636 | 25,819 | N/A | N/A |
| End Cash Position | 78,446 | 89,159 | 42,636 | N/A | N/A |
| Net Cash Flow | $-10,713 | $46,523 | $16,817 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,268 | -23,533 | -20,683 | N/A | N/A |
| Capital Expenditure | -667 | -768 | -525 | N/A | N/A |
| Free Cash Flow | -45,935 | -24,301 | -21,208 | 0 | 0 |